BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31195152)

  • 1. Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling.
    Zhao Y; Tian B; Sun H; Zhang J; Zhang Y; Ivannikov M; Motamedi M; Liu Z; Zhou J; Kaphalia L; Calhoun WJ; Maroto R; Brasier AR
    J Proteomics; 2019 Aug; 205():103415. PubMed ID: 31195152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Novel Highly Specific Bromodomain-Containing Protein 4 Inhibitors in Innate Inflammation-Driven Airway Remodeling.
    Tian B; Liu Z; Litvinov J; Maroto R; Jamaluddin M; Rytting E; Patrikeev I; Ochoa L; Vargas G; Motamedi M; Ameredes BT; Zhou J; Brasier AR
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):68-83. PubMed ID: 30153047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling.
    Tian B; Hosoki K; Liu Z; Yang J; Zhao Y; Sun H; Zhou J; Rytting E; Kaphalia L; Calhoun WJ; Sur S; Brasier AR
    J Allergy Clin Immunol; 2019 Apr; 143(4):1380-1394.e9. PubMed ID: 30321559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of BET bromodomain inhibitor JQ1 in treating airway remodeling in asthmatic mice].
    Zhu XH; Li QG; Wang J; Hu GZ; Liu ZQ; Hu QH; Wu G
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Dec; 19(12):1278-1284. PubMed ID: 29237530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns.
    Tian B; Patrikeev I; Ochoa L; Vargas G; Belanger KK; Litvinov J; Boldogh I; Ameredes BT; Motamedi M; Brasier AR
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):506-520. PubMed ID: 27911568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling.
    Brasier AR; Zhou J
    Drug Discov Today; 2020 Jan; 25(1):126-132. PubMed ID: 31733396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targets for inflammation-mediated airway remodeling in chronic lung disease.
    Brasier AR
    Expert Rev Respir Med; 2018 Nov; 12(11):931-939. PubMed ID: 30241450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling.
    Brasier AR
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32331282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.
    Tang X; Peng R; Phillips JE; Deguzman J; Ren Y; Apparsundaram S; Luo Q; Bauer CM; Fuentes ME; DeMartino JA; Tyagi G; Garrido R; Hogaboam CM; Denton CP; Holmes AM; Kitson C; Stevenson CS; Budd DC
    Am J Pathol; 2013 Aug; 183(2):470-9. PubMed ID: 23759512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation.
    Liu Z; Tian B; Chen H; Wang P; Brasier AR; Zhou J
    Eur J Med Chem; 2018 May; 151():450-461. PubMed ID: 29649741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain-containing protein 4 contributes to renal fibrosis through the induction of epithelial-mesenchymal transition.
    Wang X; Zhou Y; Peng Y; Huang T; Xia F; Yang T; Duan Q; Zhang W
    Exp Cell Res; 2019 Oct; 383(2):111507. PubMed ID: 31356816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Garofalo RP; Brasier AR
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodomain Containing Protein 4 (BRD4) Regulates Expression of its Interacting Coactivators in the Innate Response to Respiratory Syncytial Virus.
    Xu X; Mann M; Qiao D; Li Y; Zhou J; Brasier AR
    Front Mol Biosci; 2021; 8():728661. PubMed ID: 34765643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level laser therapy attenuates lung inflammation and airway remodeling in a murine model of idiopathic pulmonary fibrosis: Relevance to cytokines secretion from lung structural cells.
    de Brito AA; da Silveira EC; Rigonato-Oliveira NC; Soares SS; Brandao-Rangel MAR; Soares CR; Santos TG; Alves CE; Herculano KZ; Vieira RP; Lino-Dos-Santos-Franco A; Albertini R; Aimbire F; de Oliveira AP
    J Photochem Photobiol B; 2020 Jan; 203():111731. PubMed ID: 31935633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR3 inhibitor and tyrosine kinase inhibitor attenuate cigarette smoke/poly I:C-induced airway inflammation and remodeling by the EGFR/TLR3/MAPK signaling pathway.
    Jiang JJ; Chen SM; Li HY; Xie QM; Yang YM
    Eur J Pharmacol; 2021 Jan; 890():173654. PubMed ID: 33068589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting inducible epigenetic reprogramming pathways in chronic airway remodeling.
    Brasier AR; Boldogh I
    Drugs Context; 2019; 8():. PubMed ID: 31692901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
    Suarez-Alvarez B; Morgado-Pascual JL; Rayego-Mateos S; Rodriguez RM; Rodrigues-Diez R; Cannata-Ortiz P; Sanz AB; Egido J; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
    J Am Soc Nephrol; 2017 Feb; 28(2):504-519. PubMed ID: 27436852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation.
    Tian B; Liu Z; Yang J; Sun H; Zhao Y; Wakamiya M; Chen H; Rytting E; Zhou J; Brasier AR
    Cell Rep; 2018 Apr; 23(4):1138-1151. PubMed ID: 29694891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD4 is a novel therapeutic target for liver fibrosis.
    Ding N; Hah N; Yu RT; Sherman MH; Benner C; Leblanc M; He M; Liddle C; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):15713-8. PubMed ID: 26644586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangqi-Fangfeng protects against allergic airway remodeling through inhibiting epithelial-mesenchymal transition process in mice via regulating epithelial derived TGF-β1.
    Yao L; Wang S; Wei P; Bao K; Yuan W; Wang X; Zheng J; Hong M
    Phytomedicine; 2019 Nov; 64():153076. PubMed ID: 31473579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.